Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTN3A1 | O00481 | 3/20 | 0.96 |
| ▸ | MVD | P53602 | 2/20 | 0.44 |
| ▸ | FNTA | P49354 | 5/20 | 0.41 |
| ▸ | PGGT1B | P53609 | 3/20 | 0.41 |
| ▸ | FNTB | P49356 | 3/20 | 0.41 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Isopentenylpyrophosphate SCHEMBL125521 | 0.98 | BTN3A1 (1.00) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL15053699 | 0.98 | BTN3A1 (1.00) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL29787025 | 0.96 | BTN3A1 (0.96) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL4363351 | 0.96 | BTN3A1 (0.96) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL2027470 | 0.96 | BTN3A1 (0.96) | BTN3A1MVDFNTAPGGT1BFNTB | |
| SCHEMBL3221121 | 0.94 | BTN3A1 (0.93) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL21571357 | 0.94 | BTN3A1 (0.93) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL21571270 | 0.91 | BTN3A1 (0.86) | BTN3A1MVDFNTAPGGT1BFNTB | |
| SCHEMBL3211424 | 0.90 | BTN3A1 (0.85) | BTN3A1MVDFNTAPGGT1BFNTB | |
| Isopentenylpyrophosphate SCHEMBL28764772 | 0.90 | BTN3A1 (0.83) | BTN3A1MVDFNTAPGGT1BFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713469-A1 | METHOD OF REDUCING EMULSION FORMATIONDURING FERMENTATION PROCESS | DSM IP Assets B.V. (NL) | 2026-03-25 | — | — | EP | disclosed |
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | AMYRIS INC (US) | 2026-03-12 | — | — | US | disclosed |
| EP-2217711-B2 | PRODUCTION OF ISOPRENOIDS | AMYRIS INC (US) | 2025-04-23 | — | — | EP | disclosed |
| US-20250122551-A1 | PRODUCTION OF ISOPRENOIDS | EUAGORE, LLC | 2025-04-17 | — | — | US | disclosed |
| EP-4536615-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | Amyris, Inc. (US) | 2025-04-16 | — | — | EP | disclosed |
| WO-2024235968-A1 | METHOD OF REDUCING EMULSION FORMATIONDURING FERMENTATION PROCESS | DSM IP ASSETS B.V. (NL) | 2024-11-21 | — | — | WO | disclosed |
| US-12146176-B2 | Production of isoprenoids | Amyris, Inc. (US) | 2024-11-19 | — | — | US | disclosed |
| EP-3665292-B1 | PROCESS FOR RECOVERING ISOPRENOIDS PRODUCED BY MICROORGANISMS | TOTAL RAFFINAGE CHIMIE (FR) | 2024-03-06 | — | — | EP | disclosed |
| US-20240035061-A1 | PRODUCTION OF ISOPRENOIDS | EUAGORE, LLC | 2024-02-01 | — | — | US | disclosed |
| WO-2023239939-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | Amyris, Inc. (US) | 2023-12-14 | — | — | WO | disclosed |
| US-7659097-B2 | Production of isoprenoids | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2010-02-09 | — | — | US | disclosed |
| US-20090203019-A1 | Methods of Monitoring Metabolic Pathways | EUAGORE, LLC | 2009-08-13 | — | — | US | disclosed |
| WO-2009097339-A1 | METHODS OF MONITORING METABOLIC PATHWAYS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2009-08-06 | — | — | WO | disclosed |
| CN-101484584-A | Production of isoprenoids | AMYRIS BIOTECHNOLOGIES INC (US) | 2009-07-15 | — | — | CN | disclosed |
| US-20090137014-A1 | PRODUCTION OF ISOPRENOIDS | EUAGORE, LLC | 2009-05-28 | — | — | US | disclosed |
| WO-2009042070-A2 | PRODUCTION OF ISOPRENOIDS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2009-04-02 | — | — | WO | disclosed |
| EP-2024504-A2 | PRODUCTION OF ISOPRENOIDS | Amyris Biotechnologies, Inc. (US) | 2009-02-18 | — | — | EP | disclosed |
| US-20080274523-A1 | PRODUCTION OF ISOPRENOIDS | EUAGORE, LLC | 2008-11-06 | — | — | US | disclosed |
| WO-2008128159-A1 | PRODUCTION OF ISOPRENOIDS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2008-10-23 | — | — | WO | disclosed |
| WO-2007140339-A2 | PRODUCTION OF ISOPRENOIDS | AMYRIS BIOTECHNOLOGIES, INC. (US) | 2007-12-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | RHOA, NFATC1, CYP46A1 | BTN3A1 4489/4885MVD 998/4885FNTA 28/4885 |
| US-20090203019-A1 | Methods of Monitoring Metabolic Pathways | COASY, FDPS, GGPS1 | BTN3A1 4860/4885MVD 227/4885FNTA 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.